Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

Stress may speed growth of melanoma tumors

Stress may speed growth of melanoma tumors

Virotherapy treatment kills prostate cancer cells

Virotherapy treatment kills prostate cancer cells

Sun Pharmaceutical receives FDA approvals for 4 generics

Sun Pharmaceutical receives FDA approvals for 4 generics

Cylene Pharmaceuticals starts CX-4945 trial - first-in class inhibitor of CK2

Cylene Pharmaceuticals starts CX-4945 trial - first-in class inhibitor of CK2

New therapy for transplant rejection

New therapy for transplant rejection

FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas

FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas

Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer

Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma

Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Xencor presents data on anti-CD19 and anti-CD40 antibodies

New data on ZOLINZA (vorinostat) in combination with Bortezomib

New data on ZOLINZA (vorinostat) in combination with Bortezomib

EntreMed starts trial of ENMD-2076 in refractory multiple myeloma patients

EntreMed starts trial of ENMD-2076 in refractory multiple myeloma patients

Drug combo improves or stabilizes disease for relapsed multiple myeloma patients

Drug combo improves or stabilizes disease for relapsed multiple myeloma patients

Lenalidomide safe for elderly patients with chronic lymphocytic leukemia

Lenalidomide safe for elderly patients with chronic lymphocytic leukemia

Novel therapeutic approaches for various forms of thrombocytopenia

Novel therapeutic approaches for various forms of thrombocytopenia

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Researchers focus on phosphoinositide 3-kinase pathway in cancer research

Researchers focus on phosphoinositide 3-kinase pathway in cancer research

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

On the trail of a targeted therapy for blood cancer

On the trail of a targeted therapy for blood cancer